Receptos, Inc.

company

Overview

Receptos is utilizing proprietary G protein-coupled receptor (GPCR) technology to develop first-in-class therapeutics.

Financial Information

Areas of Expertise

Technologies involved in:

GPCR Targeted Therapeutics, Small molecule, add other

Medical focus:

Multiple sclerosis

Corporate Information

Webpage http://www.receptos.com/
Headquarters
Industries

Products

Therapeutics on the Market

Product Developed By 2007 Sales ($M) 2006 Sales ($M) 2005 Sales ($M) Indications / Phase of Development

Products on the Market

Product Brand Name Developed By 2007 Sales ($M)

Therapeutics in Development

Product Developed By Indications / Phase of Development 

Products in Development

Product Brand Name Overview